Literature DB >> 6357118

The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials.

N Wolmark, H S Wieand, H E Rockette, B Fisher, A Glass, W Lawrence, H Lerner, A B Cruz, H Volk, H Shibata.   

Abstract

The present study examines the prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Data were obtained from 1021 patients entered into two randomized prospective clinical trials of the NSABP. Tumor location proved to be a strong prognostic discriminant. Lesions located in the left colon demonstrated the most favorable prognosis. Tumors of the rectosigmoid and rectum had the worst prognosis with the relative risk of treatment failure for the latter being over three fold that of the left colon. When the relative risks associated with tumor location were adjusted for nodal imbalances, the left colon continued to demonstrate the most favorable prognosis. The presence of bowel obstruction also strongly influenced the prognostic outcome. Examination of the data without considering tumor location disclosed that patients with bowel obstruction were at greater risk for treatment failure than those without obstruction. The effect of bowel obstruction was influenced by the location of the tumor. The occurrence of bowel obstruction in the right colon was associated with a significantly diminished disease-free survival, whereas obstruction in the left colon demonstrated no such effect. This phenomenon was independent of nodal status and tumor encirclement, the latter two factors proving to be of prognostic significance independent of tumor obstruction. A multivariate analysis in which the covariate effects of sex, age, nodal status, tumor obstruction, encirclement, and tumor location were adjusted underscored the role of tumor location and obstruction as prognostic discriminants. The results indicate that the definition of prognostic factors can identify patient subsets with unique characteristics.

Entities:  

Mesh:

Year:  1983        PMID: 6357118      PMCID: PMC1353224          DOI: 10.1097/00000658-198312000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Some prognostic factors in survival of patients with cancer of the colon and rectum.

Authors:  J D Godwin; C C Brown
Journal:  J Chronic Dis       Date:  1975-10

2.  COMPARISON OF OBSTRUCTING AND NONOBSTRUCTING CARCINOMA OF THE COLON.

Authors:  J J MINSTER
Journal:  Cancer       Date:  1964-02       Impact factor: 6.860

3.  Carcinoma of the rectum; a study of factors influencing survival following combined abdominoperineal resection of the rectum.

Authors:  E J DUNNING; T E JONES; J B HAZARD
Journal:  Ann Surg       Date:  1951-02       Impact factor: 12.969

4.  Factors influencing survival after resection in cancer of the colon and rectum.

Authors:  R W Dwight; G A Higgins; R J Keehn
Journal:  Am J Surg       Date:  1969-04       Impact factor: 2.565

5.  Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma.

Authors:  J S Spratt; H J Spjut
Journal:  Cancer       Date:  1967-11       Impact factor: 6.860

6.  Analysis of variance and covariance for colorectal adenocarcinomas in man as a logical prelude to "staging".

Authors:  F R Watson; J S Spratt; R J LeDuc
Journal:  J Surg Oncol       Date:  1976       Impact factor: 3.454

7.  Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons.

Authors:  J T Evans; J Vana; B L Aronoff; H W Baker; G P Murphy
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

8.  Carcinoma of the colon and rectum in a defined population. An epidemiological, clinical and postmortem investigation of colorectal carcinoma and coexisting benign polyps in Malmö, Sweden.

Authors:  T Berge; G Ekelund; C Mellner; B Pihl; A Wenckert
Journal:  Acta Chir Scand Suppl       Date:  1973

9.  Tumor size and regional lymph node metastasis in colorectal cancer. A preliminary analysis from the NSABP clinical trials.

Authors:  N Wolmark; I Cruz; C K Redmond; B Fisher; E R Fisher
Journal:  Cancer       Date:  1983-04-01       Impact factor: 6.860

10.  Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum.

Authors:  A W Malcolm; N P Perencevich; R M Olson; J A Hanley; J T Chaffey; R E Wilson
Journal:  Surg Gynecol Obstet       Date:  1981-02
View more
  29 in total

1.  Analysis of 230 cases of emergent surgery for obstructing colon cancer--lessons learned.

Authors:  Ahmet Kessaf Aslar; Süleyman Ozdemir; Hatim Mahmoudi; Mehmet Ayhan Kuzu
Journal:  J Gastrointest Surg       Date:  2010-10-26       Impact factor: 3.452

Review 2.  Challenges in the management of stage II colon cancer.

Authors:  Efrat Dotan; Steven J Cohen
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

3.  Pathophysiology of motility dysfunction in bowel obstruction: role of stretch-induced COX-2.

Authors:  Xuan-Zheng Shi; You-Min Lin; Don W Powell; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-04       Impact factor: 4.052

4.  Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.

Authors:  Yusuke Okuda; Takaya Shimura; Tomonori Yamada; Yoshikazu Hirata; Ryuzo Yamaguchi; Eiji Sakamoto; Hiromi Kataoka
Journal:  Int J Clin Oncol       Date:  2018-06-15       Impact factor: 3.402

5.  Adjuvant treatment in colorectal cancer: an update.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

6.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

7.  Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy.

Authors:  Patrick Chun; Zev A Wainberg
Journal:  Gastrointest Cancer Res       Date:  2009-09

8.  The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.

Authors:  N Wolmark; B Fisher; H S Wieand; R S Henry; H Lerner; S Legault-Poisson; P J Deckers; N Dimitrov; P H Gordon; P Jochimsen
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

9.  Mortality in patients with obstructing colorectal cancer.

Authors:  R P Waldron; I A Donovan
Journal:  Ann R Coll Surg Engl       Date:  1986-07       Impact factor: 1.891

10.  Comparison of colorectal and gastric cancer: survival and prognostic factors.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.